Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Veit Erpenbeck (Basel, Switzerland), Veit J. Erpenbeck, Todor A. Popov, S. David Miller, Steven F. Weinstein, Sheldon Spector, Baldur Magnusson, Wande Osuntokun, Paul Goldsmith, Markus Weiss, Jutta Beier. QAW039 (fevipiprant) improves lung function and control of asthma symptoms in patients with more severe air flow limitation: A proof-of-concept study. Eur Respir J 2015; 46: Suppl. 59, 2125

Member's Comments

No comment yet.

Related content which might interest you: Montelukast improves air trapping, not airway remodeling, in moderate-to-severe patients with asthma: A pilot tudy Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 An extensive function evaluation in severe asthma with airflow limitation Source: International Congress 2014 – Asthma: still a heterogeneous condition! Year: 2014 A new observer independent method to assess therapy response in children with severe asthma based on daily lung function Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Reproducibility and stability of severe asthma research program (SARP) clinical cluster phenotypes in SARP3 Source: International Congress 2016 – Phenotyping asthma Year: 2016 Characterisation of asthma patients with persistent airflow obstruction Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Comparison of clinical features of severe persistent asthma and refractory asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 LATE-BREAKING ABSTRACT: Benralizumab reduces exacerbations in severe, uncontrolled asthma: Results of the phase III CALIMA trial Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 LATE-BREAKING ABSTRACT: Benralizumab for mild to moderate, persistent asthma: The BISE phase III study Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Tiotropium for uncontrolled asthma (a meta-analysis) Source: Annual Congress 2013 –Treatment of asthma Year: 2013 The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 LATE-BREAKING ABSTRACT: Benralizumab provides significant improvements for patients with severe, uncontrolled asthma: SIROCCO Phase III results Source: International Congress 2016 – Novel strategies on COPD and asthma management Year: 2016 Is sustained control of severe asthma possible? A composite score to assess 1-year of asthma control Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Managing asthma patients: which outcomes matter? Source: Eur Respir Rev 2008; 17: 53-61 Year: 2008 Additive layer manufacturing of physiologically realistic patient specific airway models for study of flow modifications in asthma and COPD Source: Annual Congress 2013 –Functional imaging Year: 2013 TH2 specific biomarker profile determines steroid responsiveness in severe asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 The influence of bronchial asthma as a comorbidity of COPD on the COPD assessment test (CAT) Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Higher burden of asthma symptoms and increased blood eosinophils in ACOS Source: International Congress 2016 – Systemic biomarkers Year: 2016 Predictors of long-term lung function decline in adult-onset asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016